Entity Details

Primary name CPT2
Entity type gene
Source Source Link

Details

PrimaryID1376
RefseqGeneNG_008035
SymbolCPT2
Namecarnitine palmitoyltransferase 2
Chromosome1
Location1p32.3
TaxID9606
Statuslive
SourceGenomegenomic
SourceOriginnatural
CreationDate1998-08-14
ModificationDate2021-06-11

Ontological Relatives

UniProt IDsCPT2_HUMAN

GO terms

Show/Hide Table
GOName
GO:0001676 long-chain fatty acid metabolic process
GO:0004095 carnitine O-palmitoyltransferase activity
GO:0005654 nucleoplasm
GO:0005730 nucleolus
GO:0005739 mitochondrion
GO:0005743 mitochondrial inner membrane
GO:0006635 fatty acid beta-oxidation
GO:0006853 carnitine shuttle
GO:0008458 carnitine O-octanoyltransferase activity
GO:0009437 carnitine metabolic process
GO:0016746 acyltransferase activity
GO:0019222 regulation of metabolic process
GO:0120162 positive regulation of cold-induced thermogenesis

Diseases

Show/Hide Table
Disease IDSourceNameDescription
608836 OMIMCarnitine palmitoyltransferase 2 deficiency, lethal neonatal (CPT2DLN)An autosomal recessive disorder of mitochondrial long-chain fatty acid oxidation with fatal outcome, presenting shortly after birth. It is characterized by respiratory distress, seizures, altered mental status, hepatomegaly, cardiomegaly, cardiac arrhythmia, and, in many cases, dysmorphic features, renal dysgenesis, and migration defects. recessive. The disease is caused by variants affecting the gene represented in this entry.
255110 OMIMCarnitine palmitoyltransferase 2 deficiency, myopathic, stress-induced (CPT2D)An autosomal recessive disorder of mitochondrial long-chain fatty acid oxidation, characterized by recurrent myoglobinuria, episodes of muscle pain, stiffness, and rhabdomyolysis. These symptoms are exacerbated by prolonged exercise, fasting, cold, or viral infection. CPT2DM affects most frequently children or young adults, and severity of attacks is highly variable. Myoglobinuria can cause kidney failure and death. The disease is caused by variants affecting the gene represented in this entry.
600649 OMIMCarnitine palmitoyltransferase 2 deficiency, infantile (CPT2DI)An autosomal recessive disorder of mitochondrial long-chain fatty acid oxidation, characterized by hepatic or hepato-cardio-muscular manifestations with onset in infancy. Clinical features include hypoketotic hypoglycemia, lethargy, seizures, hepatomegaly, liver dysfunction, cardiomegaly and dilated cardiomyopathy. The disease is caused by variants affecting the gene represented in this entry.
614212 OMIMEncephalopathy, acute, infection-induced, 4 (IIAE4)A severe neurologic complication of an infection. It manifests within days in otherwise healthy children after common viral infections, without evidence of viral infection of the brain or inflammatory cell infiltration. In affected children, high-grade fever is accompanied within 12 to 48 hours by febrile convulsions, often leading to coma, multiple-organ failure, brain edema, and high morbidity and mortality. The infections are usually viral, particularly influenza, although other viruses and even mycoplasma have been found to cause the disorder. Disease susceptibility is associated with variants affecting the gene represented in this entry. CPT2 polymorphic variants do not cause classical carnitine palmitoyltransferase 2 deficiency, and patients harboring any of them are asymptomatic most of the time. However, they are prone to viral infection (high fever)-related encephalopathy (PubMed:21697855).

Interactions

41 interactions

InteractorPartnerSourcesPublicationsLink
CPT2CYSRT1IntAct32296183 details
CPT2OTX1IntAct32296183 details
CPT2SYVN1BioGRID33207079 details
CPT2MRPL58BioGRID, MINT20186120 details
CPT2HSCBBioGRID, IntAct28380382 details
CPT2APLNRBioGRID, IntAct28514442 details
CPT2ATP5F1DBioGRID, IntAct28514442 details
CPT2NDUFA13BioGRID, IntAct28514442 details
CPT2MCL1BioGRID, IntAct26186194 28514442 details
CPT2FAHD1BioGRID, IntAct26186194 28514442 details
CPT2MRM3BioGRID, IntAct28514442 details
CPT2TMEM70BioGRID, IntAct28514442 details
CPT2GNASBioGRID, IntAct26186194 28514442 details
CPT2MCUR1BioGRID, IntAct28514442 32877691 details
CPT2ARHGEF26BioGRID, IntAct26186194 28514442 details
CPT2C15orf48BioGRID, IntAct27499296 details
CPT2MAIP1BioGRID, IntAct27499296 details
CPT2COQ9BioGRID, IntAct27499296 details
CPT2NDUFA4BioGRID, IntAct27499296 details
CPT2NDUFS3BioGRID, IntAct26186194 27499296 details
CPT2PTPMT1BioGRID, IntAct27499296 details
CPT2TEX101BioGRID, UniProt30097533 details
CPT2ATF6BBioGRID26186194 details
CPT2ARG2BioGRID26186194 details
CPT2OXLD1BioGRID26186194 details
CPT2ALDH7A1BioGRID26344197 details
CPT2ATP1B1BioGRID26344197 details
CPT2ATP1B3BioGRID26344197 details
CPT2ATP5MGBioGRID26344197 details
CPT2SCCPDHBioGRID26344197 details
CPT2TOMM40BioGRID26344197 details
CPT2UQCRQBioGRID26344197 details
CPT2HCCSBioGRID26344197 details
CPT2COQ8ABioGRID27499296 details
CPT2NDUFAF8BioGRID27499296 details
CPT2RAB32BioGRID31536960 details
CPT2SQORBioGRID31536960 details
CPT2KCTD10BioGRID31280863 details
CPT2GATD3BioGRID32877691 details
CPT2COX15BioGRID32877691 details
CPT2MTDHBioGRID22199357 details